×
About 180 results

ALLMedicine™ Glaucoma Filtering Center

Research & Reviews  63 results

Analysis of the systemic exposure of Mitomycin C used in glaucoma filtering surgery amo...
https://doi.org/10.1080/02713683.2023.2189636
Current Eye Research; Angmo D, Mahalingam K et. al.

Mar 10th, 2023 - Systemic absorbtion of topically applied mitomycin C (MMC) during trabeculectomy needs to be evaluated to look for any systemic toxicity, which might be a major concern in certain conditions like pregnancy. After obtaining ethical committee cleara...

PREVALENCE, CHARACTERISTICS, AND OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN EYES ...
https://doi.org/10.1097/IAE.0000000000003587
Retina (Philadelphia, Pa.); Starr MR, Huang D et. al.

Aug 14th, 2022 - To describe the prevalence, management, and outcomes of rhegmatogenous retinal detachment (RRD) after incisional glaucoma filtering surgery. All patients with a history of trabeculectomy or glaucoma drainage device surgery who were subsequently di...

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma
https://clinicaltrials.gov/ct2/show/NCT03480711

Jul 19th, 2022 - Different surgical procedures were developed and the principle behind them was to establish a fistula between the anterior chamber and the subconjunctival space to permit the aqueous humour to exit the eye. Subscleral trabeculectomy has remained t...

Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy
https://clinicaltrials.gov/ct2/show/NCT03107000

May 5th, 2022 - Corneal endothelial cells health and pumping function is crucial to permit corneal optical clarity by keeping the cornea in a relatively dehydrated state.1 The corneal endothelium is a single layer of hexagonal cells with uniform size and shape in...

Reintervention rate in glaucoma filtering surgery: A systematic review and meta-analysis.
https://doi.org/10.1177/11206721221093828
European Journal of Ophthalmology; Marolo P, Reibaldi M et. al.

Apr 28th, 2022 - Reintervention rate is an important factor impacting on patients, surgeons, and society. To date, only a few studies have focused on this topic. For this reason, a systematic review and meta-analysis was undertaken to assess the reintervention rat...

see more →

Clinicaltrials.gov  9 results

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma
https://clinicaltrials.gov/ct2/show/NCT03480711

Jul 19th, 2022 - Different surgical procedures were developed and the principle behind them was to establish a fistula between the anterior chamber and the subconjunctival space to permit the aqueous humour to exit the eye. Subscleral trabeculectomy has remained t...

Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy
https://clinicaltrials.gov/ct2/show/NCT03107000

May 5th, 2022 - Corneal endothelial cells health and pumping function is crucial to permit corneal optical clarity by keeping the cornea in a relatively dehydrated state.1 The corneal endothelium is a single layer of hexagonal cells with uniform size and shape in...

Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery
https://clinicaltrials.gov/ct2/show/NCT00238563

Sep 11th, 2019 - Postoperative sub-Tenon Triamcinolone Acetonide in glaucoma filtering surgery Objectives: Trabeculectomy is a surgical procedure designed to reduce internal eye pressure by draining fluid from within the eye to the sub-conjunctival (superficial ey...

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
https://clinicaltrials.gov/ct2/show/NCT01440751

Nov 1st, 2017 - "ologen ® CM" is a biodegradable collagen matrix. To prevent episcleral fibrosis and subconjunctival scarring thay may result in the surgical failure in trabeculectomy, its sporous matrix modulates the migrations and proliferations of fibroblasts ...

A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt
https://clinicaltrials.gov/ct2/show/NCT02173223

Apr 24th, 2015 - A. To evaluate the ocular hypotensive efficacy of the rho-kinase Inhibitor (AR-12286 0.5% and 0.7%) ophthalmic solutions in glaucoma patients with failed prior glaucoma filtering surgery and uncontrolled IOP who are facing further surgical interve...

see more →